{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:14:50Z","timestamp":1787026490196,"version":"build-2736575974"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Leigh syndrome is a rare, genetic, and severe mitochondrial disorder characterized by neuromuscular issues (ataxia, seizure, hypotonia, developmental delay, dystonia) and ocular abnormalities (nystagmus, atrophy, strabismus, ptosis). It is caused by pathogenic variants in either mitochondrial or nuclear DNA genes, with an estimated incidence rate of 1 per 40,000 live births.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Case presentation:<\/jats:bold>\n                    Herein, we present an infant male with nystagmus, hypotonia, and developmental delay who carried a clinical diagnosis of Leigh-like syndrome. Cerebral magnetic resonance imaging changes further supported the clinical evidence of an underlying mitochondrial disorder, but extensive diagnostic testing was negative. Trio exome sequencing under a research protocol uncovered compound-heterozygous missense variants in the\n                    <jats:italic>HTRA2<\/jats:italic>\n                    gene (MIM: #606441): NM_013247.5:c.1037A&amp;gt;T:(p.Glu346Val) (maternal) and NM_013247.5:c.1172T&amp;gt;A:(p.Val391Glu) (paternal). Both variants are absent from public databases, making them extremely rare in the population. The maternal variant is adjacent to an exon-intron boundary and predicted to disrupt splicing, while the paternal variant alters a highly conserved amino acid and is predicted to be damaging by nearly all\n                    <jats:italic>in silico<\/jats:italic>\n                    tools. Biallelic variants in\n                    <jats:italic>HTRA2<\/jats:italic>\n                    cause 3-methylglutaconic aciduria, type VIII (MGCA8), an extremely rare autosomal recessive disorder with fewer than ten families reported to date. Variant interpretation is challenging given the paucity of known disease-causing variants, and indeed we assess both paternal and maternal variants as Variants of Uncertain Significance under current American College of Medical Genetics guidelines. However, based on the inheritance pattern, suggestive evidence of pathogenicity, and significant clinical correlation with other reported MGCA8 patients, the clinical care team considers this a diagnostic result.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Our findings ended the diagnostic odyssey for this family and provide further insights into the genetic and clinical spectrum of this critically under-studied disorder.\n                  <\/jats:p>","DOI":"10.3389\/fgene.2023.1298574","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T23:22:25Z","timestamp":1705533745000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Biallelic variants in HTRA2 cause 3-methylglutaconic aciduria mitochondrial disorder: case report and literature review"],"prefix":"10.3389","volume":"14","author":[{"given":"Umamaheswaran","family":"Gurusamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetha","family":"Ramadesikan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Marhabaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlyn M.","family":"Colwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse M.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco L.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine R.","family":"Mardis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murugu","family":"Manickam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Koboldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/s0022-3476(99)70126-5","article-title":"Genetic analysis of the G4.5 gene in families with suspected Barth syndrome","volume":"135","author":"Cantlay","year":"1999","journal-title":"J. Pediatr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/ana.75","article-title":"The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities","volume":"49","author":"Darin","year":"2001","journal-title":"Ann. Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.pediatrneurol.2008.07.013","article-title":"Leigh and Leigh-like syndrome in children and adults","volume":"39","author":"Finsterer","year":"2008","journal-title":"Pediatr. Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"16080","DOI":"10.1038\/nrdp.2016.80","article-title":"Mitochondrial diseases","volume":"2","author":"Gorman","year":"","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B5","doi-asserted-by":"publisher","first-page":"16080","DOI":"10.1038\/nrdp.2016.80","article-title":"Mitochondrial diseases","volume":"2","author":"Gorman","year":"","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B6","doi-asserted-by":"publisher","first-page":"18285","DOI":"10.1073\/pnas.1419581111","article-title":"Mitochondrial serine protease HTRA2 p.G399S in a kindred with essential tremor and Parkinson disease","volume":"111","author":"Gulsuner","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B7","volume-title":"A quick guide to quick guide to metabolic disease testing interpretation","author":"Jones","year":"2020"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13059-014-0577-x","article-title":"Churchill: an ultra-fast, deterministic, highly scalable, and balanced parallelization strategy for the discovery of human genetic variation in clinical and population-scale genomics","volume":"16","author":"Kelly","year":"2015","journal-title":"Genome Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"a002410","DOI":"10.1101\/mcs.a002410","article-title":"A de novo nonsense mutation in ASXL3 shared by siblings with Bainbridge\u2013 Ropers syndrome","volume":"4","author":"Koboldt","year":"2018","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"B10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1055\/s-0038-1667345","article-title":"HTRA2 defect: a recognizable inborn error of metabolism with 3- methylglutaconic aciduria as discriminating feature characterized by neonatal movement disorder and epilepsy-report of 11 patients","volume":"49","author":"Kovacs-Nagy","year":"2018","journal-title":"Neuropediatrics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/jnnp.14.3.216","article-title":"Subacute necrotizing encephalomyelopathy in an infant","volume":"14","author":"Leigh","year":"1951","journal-title":"J. Neurol. Neurosurg. Psychiat."},{"key":"B12","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1136\/jmedgenet-2016-103922","article-title":"Deficiency of HTRA2\/Omi is associated with infantile neurodegeneration and 3- methylglutaconic aciduria","volume":"53","author":"Mandel","year":"2016","journal-title":"J. Med. Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1212\/wnl.39.5.697","article-title":"Cytochrome c oxidase deficiency in Leigh\u2019s syndrome: genetic evidence for a nuclear DNA-encoded mutation","volume":"39","author":"Miranda","year":"1989","journal-title":"Neurology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10545-016-9977-2","article-title":"Pathogenic variants in HTRA2 cause an early-onset mitochondrial syndrome associated with 3-methylglutaconic aciduria","volume":"40","author":"Olahova","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/B978-0-12-821751-1.00015-4","article-title":"Leigh syndrome","volume":"194","author":"Rahman","year":"2023","journal-title":"Handb. Clin. Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ana.410390311","article-title":"Leigh syndrome: clinical features and biochemical and DNA abnormalities","volume":"39","author":"Rahman","year":"1996","journal-title":"Ann. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/08035250410022837","article-title":"Barth syndrome without 3-methylglutaconic aciduria","volume":"93","author":"Schmidt","year":"2004","journal-title":"Acta Paediatr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1093\/hmg\/ddn096","article-title":"Sequencing analysis of OMI\/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls","volume":"17","author":"Sim\u00f3n-S\u00e1nchez","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/bdr2.1717","article-title":"3-Methylglutaconic aciduria type VIII in an Indian neonate","volume":"112","author":"Sreedhara","year":"2020","journal-title":"Birth Defects Res."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1298574\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T23:22:27Z","timestamp":1705533747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1298574\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":20,"alternative-id":["10.3389\/fgene.2023.1298574"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2023.1298574","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"article-number":"1298574"}}